Slevin ML - Search Results

1

Calvert AH, Horwich A, Newlands ES, Begent R, Rustin GJ, Kaye SB, Harris AL, Williams CJ, Slevin ML. Calvert AH, et al. Among authors: slevin ml. Lancet. 1988 Sep 3;2(8610):577-8. doi: 10.1016/s0140-6736(88)92709-2. Lancet. 1988. PMID: 2900968 No abstract available.

2

Chemotherapy for ovarian cancer--a consensus statement on standard practice.

Adams M, Calvert AH, Carmichael J, Clark PI, Coleman RE, Earl HM, Gallagher CJ, Ganesan TS, Gore ME, Graham JD, Harper PG, Jayson GC, Kaye SB, Ledermann JA, Osborne RJ, Perren TJ, Poole CJ, Radford JA, Rustin GJ, Slevin ML, Smyth JF, Thomas H, Wilkinson PM. Adams M, et al. Among authors: slevin ml. Br J Cancer. 1998 Dec;78(11):1404-6. doi: 10.1038/bjc.1998.699. Br J Cancer. 1998. PMID: 9836470 Free PMC article. No abstract available.

3

A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix.

Coleman RE, Clarke JM, Slevin ML, Sweetenham J, Williams CJ, Blake P, Calman F, Wiltshaw E, Harper PG. Coleman RE, et al. Among authors: slevin ml. Cancer Chemother Pharmacol. 1990;27(1):52-4. doi: 10.1007/BF00689276. Cancer Chemother Pharmacol. 1990. PMID: 2245492

4

A multicenter phase II study of carboplatin in advanced ovarian carcinoma: final report.

Kjorstad K, Harris A, Bertelsen K, Slevin M, Schultz H, Hellman K, Janssens N, Martin A, Canetta R. Kjorstad K, et al. Ann Oncol. 1992 Mar;3(3):217-22. doi: 10.1093/oxfordjournals.annonc.a058155. Ann Oncol. 1992. PMID: 1586619 Free article. Clinical Trial.

5

Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial.

Williams CJ, Mead GM, Macbeth FR, Thompson J, Whitehouse JM, MacDonald H, Harvey VJ, Slevin ML, Lister TA, Shepherd JH, et al. Williams CJ, et al. Among authors: slevin ml. J Clin Oncol. 1985 Nov;3(11):1455-62. doi: 10.1200/JCO.1985.3.11.1455. J Clin Oncol. 1985. PMID: 3903062 Clinical Trial.

6

Phase II study of vinblastine and bleomycin in advanced ovarian cancer.

Osborne RJ, Harvey VJ, Slevin ML, Shepherd JH, Williams CJ. Osborne RJ, et al. Among authors: slevin ml. Cancer Treat Rep. 1987 Mar;71(3):335-6. Cancer Treat Rep. 1987. PMID: 2434227 No abstract available.

7

Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups.

Gore ME, Rustin G, Slevin M, Gallagher C, Penson R, Osborne R, Ledermann J, Cameron T, Thompson JM. Gore ME, et al. Br J Cancer. 1997;75(5):710-4. doi: 10.1038/bjc.1997.126. Br J Cancer. 1997. PMID: 9043029 Free PMC article. Clinical Trial.

8

Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule.

Osborne RJ, Malik ST, Slevin ML, Harvey VJ, Spona J, Salzer H, Williams CJ. Osborne RJ, et al. Among authors: slevin ml. Br J Cancer. 1988 Jan;57(1):115-6. doi: 10.1038/bjc.1988.22. Br J Cancer. 1988. PMID: 3348944 Free PMC article. No abstract available.

9

A phase II study of tamoxifen in ovarian cancer.

Slevin ML, Harvey VJ, Osborne RJ, Shepherd JH, Williams CJ, Mead GM. Slevin ML, et al. Eur J Cancer Clin Oncol. 1986 Mar;22(3):309-12. doi: 10.1016/0277-5379(86)90396-2. Eur J Cancer Clin Oncol. 1986. PMID: 3709599

10

The clinical activity of cyproterone acetate in advanced ovarian carcinoma. A London Gynaecology Oncology Group Study.

Thompson P, Wilson P, Osborne R, Slevin M, Wiltshaw F, Blake P, Harper P, Coleman R, Williams C, Sweetenham J, et al. Thompson P, et al. Br J Cancer. 1991 Nov;64(5):973-4. doi: 10.1038/bjc.1991.440. Br J Cancer. 1991. PMID: 1834157 Free PMC article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page